Domain Therapeutics

A preclinical-stage biopharmaceutical company dedicated to the discovery and development of innovative treatments for immuno-oncology.
#Drugdiscovery #GPCR #IO

[IPCMS @IPCMSlab]

The IPCMS warmly thanks @DOMAINtx for its generous donation of laboratory materials, equipment and furniture, and assures that it will be used wisely!

[Domain Therapeutics @DOMAINtx]

Sarcoma merits #precisionmedicine all year-round! At @DOMAINtx, we take pride to be working with Pr Antoine Italiano, our leading partner in the @RHUCondor against Sarcoma! Thank you, Pr Italiano, for your commitment to developing novel #immunotherapies
#sarcomaawarenessmonth

[Domain Therapeutics @DOMAINtx]

Read full article here: https://t.co/EAg4mDU2Yf

[Domain Therapeutics @DOMAINtx]

Success proven by science 👏 This is our firm belief! Our #precisionresearch & collaborations drive #pharma innovation. As leaders in #GPCR #immunooncology, we deliver cutting-edge cancer treatments. Thank you @Biotech_finance for this great article.

[Domain Therapeutics @DOMAINtx]

Best-in-class also works for choirs!
👏 Congratulations to 24 @DOMAINtx choristers for incredible performance at the solidarity concert organized by @LesBlousesRoses at the home for elderly. Music can help many of us find comfort and inspiration. #cancertreatment #immunooncology

[Domain Therapeutics @DOMAINtx]

Find out more: https://t.co/yhlq2RXHsA

[Domain Therapeutics @DOMAINtx]

@DOMAINtx announces @EPOorg decision to grant a composition of matter #patent in > 15 European countries for its proprietary EP4 receptor antagonist program, including the candidate DT-9081, solidifying company's position as a leading #innovator in the field of #immunooncology

[Domain Therapeutics @DOMAINtx]

Read full article here: https://t.co/3WRNAn6CWx

[Domain Therapeutics @DOMAINtx]

@DOMAINtx we believe in the untapped potential of #GPCRs to revolutionize #cancer treatment through #immunotherapy. Thank you @lndavid and @dnatweets for highlighting the #drugdiscovery potential of GPCRs in your recent article
#immunooncology #drugdevelopment #precisionmedicine

[Domain Therapeutics @DOMAINtx]

🚲« Bike to work » June challenge is now over:
🎯@DOMAINtx is in the top 10 ➡️ 9th out of 243
🛣️ Distance covered: nearly 10,000 km
❔ approximately 2.53 tons of CO2 emissions avoided = trip from Paris to La Réunion!
Congratulations to the Team!
@CADR67 @strasbourg #Cancer

[Domain Therapeutics @DOMAINtx]

@DOMAINtx #ImmunotherapyMonth saw some major milestones. Our #pressday spotlighted our position as the "#GPCR company" in #immunooncology, unlocking the potential of GPCRs VS cancer. Nominations of DT-9045 & DT-7012 further confirmed our commitment to innovative #cancertreatments

[Domain Therapeutics @DOMAINtx]

@gazettelabo Merci Alicia et @gazettelabo. Nous sommes ravis d'avoir pu illustrer la valeur ajoutée du portefeuille de @DOMAINtx comme société leader dans les immunothérapies ciblant les #GPCR et annoncer la nomination du DT-7012 un anticorps anti-CCR8 qui entre en développement réglementaire

[Domain Therapeutics @DOMAINtx]

To learn more on this great news, follow the link : https://t.co/ShjWI70dYX

[Domain Therapeutics @DOMAINtx]

Proud to announce the nomination of DT-7012, our best-in-class Treg-depleting CCR8 monoclonal #antibody strengthening our #pipeline of immunotherapies targeting #GPCR. With its potential & fast-track development we aim to optimize #immunotherapy effects. #precisionmedicine #IO

[Domain Therapeutics @DOMAINtx]

Hop on your bike for a greener planet! Kudos Team Domain for the effort on #auboulotavelo2023 & dedication to sustainability. Let's inspire others to join us on this eco-friendly journey. #sustainable #worklifebalance #Auboulotavelo @strasbourg @CADR67

[Domain Therapeutics @DOMAINtx]

@adMare_Bio @ThryvTrx Merci @adMare_Bio

[Domain Therapeutics @DOMAINtx]

June 5-8 I @DOMAINtx team will attend @BIOConvention 2023 in Boston. Reach out to learn more about our pipeline of best-in-class & first-in-class #GPCR-targeting assets in #immunooncology.

#BIO2023 #DrugDevelopment #DrugDesign #PrecisionMedicine #Biotech

[Domain Therapeutics @DOMAINtx]

Happy to inaugurate our new HQ with friends & partners from our #innovation ecosystem. At @DOMAINtx we push the boundaries of science to unlock new possibilities in cancer while committing to #SustainableDevelopment. Our new building reflects that. Thank you all for your support.

[Anne-Marie Jean @AnneMarieJean1]

Inauguration ce soir des nouveaux locaux de Domain Therapeutics au Parc d’Innovation. Une belle histoire de développement d’entreprise, d’innovation et d’esprit d’équipe dans une écosystème fertile, au service de la santé… tous mes vœux ! #innovation #biotech #santé

[Domain Therapeutics @DOMAINtx]

Let’s race for #research against #sarcoma & rare types of #cancer in children & young adults, opportunity to make a donation to @BERGONIE33 & contribute to @RHUCondor combining #precisionmedicine & #immunotherapies for more efficient therapeutic management of sarcoma #patients

[Ville de Pessac @Villedepessac]

📣 La Course du Petit Prince

Pour aider la recherche contre les sarcomes : cancers rares des enfants et jeunes adultes pour l’institut Bergonié.
https://t.co/gc2D4aITdz

[Domain Therapeutics @DOMAINtx]

How can we increase cancer treatment success rate & cure more #patients? 
Join @NeuvilleP at #Bioequity Europe 2023 for #presentation on our approach pioneering #GPCR #immunotherapies for #immunooncology:

15th of May / 10:10am / @TheCCD Dublin

#investments @EBDgroup @BioCentury